Veeva Systems Research and Development Expenses 2012-2024 | VEEV
Veeva Systems annual/quarterly research and development expenses history and growth rate from 2012 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
- Veeva Systems research and development expenses for the quarter ending October 31, 2024 were $0.172B, a 6.9% increase year-over-year.
- Veeva Systems research and development expenses for the twelve months ending October 31, 2024 were $0.675B, a 11.04% increase year-over-year.
- Veeva Systems annual research and development expenses for 2024 were $0.629B, a 20.9% increase from 2023.
- Veeva Systems annual research and development expenses for 2023 were $0.52B, a 36.19% increase from 2022.
- Veeva Systems annual research and development expenses for 2022 were $0.382B, a 29.85% increase from 2021.
| Veeva Systems Annual Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2024 | $629 |
| 2023 | $520 |
| 2022 | $382 |
| 2021 | $294 |
| 2020 | $210 |
| 2019 | $159 |
| 2018 | $132 |
| 2017 | $97 |
| 2016 | $66 |
| 2015 | $41 |
| 2014 | $26 |
| 2013 | $15 |
| 2012 | $8 |
| 2011 | $4 |
| Veeva Systems Quarterly Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2024-10-31 | $172 |
| 2024-07-31 | $176 |
| 2024-04-30 | $163 |
| 2024-01-31 | $164 |
| 2023-10-31 | $161 |
| 2023-07-31 | $157 |
| 2023-04-30 | $147 |
| 2023-01-31 | $143 |
| 2022-10-31 | $130 |
| 2022-07-31 | $134 |
| 2022-04-30 | $113 |
| 2022-01-31 | $105 |
| 2021-10-31 | $99 |
| 2021-07-31 | $95 |
| 2021-04-30 | $83 |
| 2021-01-31 | $82 |
| 2020-10-31 | $80 |
| 2020-07-31 | $70 |
| 2020-04-30 | $62 |
| 2020-01-31 | $61 |
| 2019-10-31 | $53 |
| 2019-07-31 | $51 |
| 2019-04-30 | $45 |
| 2019-01-31 | $43 |
| 2018-10-31 | $40 |
| 2018-07-31 | $39 |
| 2018-04-30 | $37 |
| 2018-01-31 | $37 |
| 2017-10-31 | $34 |
| 2017-07-31 | $33 |
| 2017-04-30 | $28 |
| 2017-01-31 | $26 |
| 2016-10-31 | $25 |
| 2016-07-31 | $24 |
| 2016-04-30 | $22 |
| 2016-01-31 | $20 |
| 2015-10-31 | $18 |
| 2015-07-31 | $15 |
| 2015-04-30 | $13 |
| 2015-01-31 | $12 |
| 2014-10-31 | $11 |
| 2014-07-31 | $10 |
| 2014-04-30 | $9 |
| 2014-01-31 | $8 |
| 2013-10-31 | $7 |
| 2013-07-31 | $6 |
| 2013-04-30 | $6 |
| 2013-01-31 | |
| 2012-10-31 | $4 |
| 2012-01-31 | |
| 2011-01-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $36.709B | $2.364B |
| Veeva Systems Inc. offers cloud-based software applications and data solutions for the life sciences industry. The company's product portfolio includes Veeva CRM (customer relationship management), Veeva Vault (content and information management), Veeva Network (customer master and product data management) and Veeva data services (Veeva OpenData and Veeva KOL data). | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Hims & Hers Health (HIMS) | United States | $11.210B | 183.25 |
| Tempus AI (TEM) | United States | $10.954B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $5.532B | 107.78 |
| IRhythm Technologies (IRTC) | United States | $3.734B | 0.00 |
| Privia Health (PRVA) | United States | $2.941B | 245.10 |
| Enovis (ENOV) | United States | $2.475B | 16.49 |
| Clover Health Investments (CLOV) | United States | $2.095B | 0.00 |
| Azenta (AZTA) | United States | $2.083B | 96.98 |
| Omnicell (OMCL) | United States | $1.845B | 40.23 |
| Schrodinger (SDGR) | United States | $1.580B | 0.00 |
| Phreesia (PHR) | United States | $1.577B | 0.00 |
| 10x Genomics (TXG) | United States | $1.381B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.859B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.512B | 0.00 |
| Standard BioTools (LAB) | United States | $0.495B | 0.00 |
| Talkspace (TALK) | United States | $0.481B | 285.00 |
| TruBridge (TBRG) | United States | $0.423B | 123.26 |
| Nyxoah SA (NYXH) | Belgium | $0.353B | 0.00 |
| Pulmonx (LUNG) | United States | $0.352B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.305B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.257B | 0.00 |
| American Well (AMWL) | United States | $0.174B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.097B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.085B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.075B | 0.00 |
| 111 (YI) | China | $0.072B | 0.00 |
| CareCloud (CCLD) | United States | $0.054B | 0.00 |
| HeartBeam (BEAT) | United States | $0.054B | 0.00 |
| Outset Medical (OM) | United States | $0.044B | 0.00 |
| Zepp Health (ZEPP) | China | $0.042B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.038B | 0.00 |
| Zhongchao (ZCMD) | China | $0.034B | 0.00 |
| Movano (MOVE) | United States | $0.032B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.015B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.015B | 0.00 |
| Precipio (PRPO) | United States | $0.014B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.013B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Syra Health (SYRA) | United States | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |